A carregar...

Clinical implications of molecular heterogeneity in triple negative breast cancer

Triple negative breast cancer (TNBC) is a molecularly heterogeneous disease lacking recurrent targetable alterations and thus therapeutic advances have been challenging. The absence of ER, PR and HER2 amplifications, leaves combination chemotherapy as the standard of care treatment option in the adj...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast
Main Authors: Lehmann, Brian D., Pietenpol, Jennifer A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641762/
https://ncbi.nlm.nih.gov/pubmed/26253813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2015.07.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!